JPRN-jRCTs031220045已完成未知
Examination of the effect of HP-3150 on the upper gastrointestinal mucosa in healthy middle-aged men and women
Fukase Hiroyuki0 个研究点目标入组 60 人开始时间: 2022年4月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
The incidence of gastroduodenal ulcer tended to be lower in the ZICTHORU Tapes group compared to the Loxoprofen Na tablets group. The incidence of gastroduodenal ulcer and / or erosion was about half that of the Loxoprofen Na tablets group in the ZICTHORU Tapes group. These results suggest that the ZICTHORU Tapes has a smaller effect on the upper gastrointestinal mucosa than existing oral NSAIDs.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 40age old 至 < 75age old（—）
- 性别
- All
入选标准
- •(1) Japanese healthy adult men and women between 40 and 75 years old at the date of consent
- •(2) The person himself / herself has received a thorough explanation of the study drug and the purpose / content of the research, voluntarily volunteered and has agreed in writing to participate in the clinical research
排除标准
- •(1) Those with gastrointestinal tract symptoms
- •(2) Those who have or have a history of gastrointestinal ulcer
- •(3) Those who have a history of gastrointestinal tract disease within 4 weeks before the start of the observation period
- •(4) Those who used the following drugs within 4 weeks before the start of the observation period
- •-NSAIDs containing study drugs (including aspirin)
- •-Anti-ulcer drug
- •-Systemic steroids
- •-Antibacterial drug
- •However, local preparations that are not considered to affect the evaluation of upper gastrointestinal ulcer are excluded
- •-Bisphosphonate osteoporosis drug
- •(5) Those who have ulcers, erosions, 11 or more petechiae or active bleeding in the esophagus, stomach, pylorus and / or duodenum in upper gastrointestinal endoscopy on start date of administration of study drugs
- •(6) Those who have positive test results for H. pylori positive by the test at the beginning of the observation period
- •(7) Persons with diseases that are contraindicated in the package insert of ZICTHORU Tapes or loxonin tablets
- •(8) Those who are pregnant, nursing , possibly pregnant or breastfeeding
- •(9) Those who do not agree to use proper contraception during the study period
- •(10) Those who do not ag ree to report a pregnancy during the study and those who do not agree to attend follow-up visits of the mother and child for up to 1 month after birth
- •(11) Those who know that their skin is sensitive to external preparations (including over-the-counterdrugs) and adhesive bandages
- •(12) Those who cannot secure the study drug administration site due to body hair, or those who cannot secure the planned site of administration due to skin abnormalities, tattoos or nevus or those who frequently sunburn the skin
- •(13) Participants who have participated in other clinical studies or trials within 16 weeks before the start of the study drug administration
- •(14) Other persons who are judged to be ineligible for this study by the Principal Investigator or Sub-Investigator
研究者
相似试验
Unknown
不适用
The Effect of PPI Therapy on the Result of Helicobacter Pylori Diagnostic TestsHelicobacter PyloriNCT01278901Rabin Medical Center30
撤回
4 期
Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus ControlPositive Helicobacter Pylori SerologyCoronary ThrombosisSupra-aortic Artery ThrombosisNCT00713947Assistance Publique - Hôpitaux de Paris
已完成
不适用
Serum Zinc, Peptic Ulcer Disease and H. Pylori InfectionPeptic Ulcer DiseaseNCT02716025Ain Shams University75
已完成
3 期
A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated UlcersGastric UlcerNCT00961350POZEN530
已完成
3 期
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated UlcersGastric UlcerNCT00960869POZEN519